BioRestorative Therapies (BRTX) Interest Expense - Others (2015 - 2022)
BioRestorative Therapies' (BRTX) quarterly Interest Expense - Others came in at $46613.0 in Q2 2022, down 90.81% on a YoY basis from $507332.0 in Q2 2021, and up 60.67% quarter-over-quarter from $29011.0 in Q1 2022.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Interest Expense - Others (2015 - 2022) Analysis & Trends
BioRestorative Therapies (BRTX) has reported Interest Expense - Others for 8 consecutive years, with $46613.0 the latest figure, recorded in Q2 2022.
- For the quarter ending Q2 2022, Interest Expense - Others fell 90.81% year-over-year to $46613.0; the trailing twelve-month figure through Jun 2022 stood at $784984.0 (down 18.16% YoY), and the FY2021 full-year result was $1.8 million, up 10.68% from the prior year.
- Interest Expense - Others grew to $46613.0 in Q2 2022 per BRTX's latest filing, from $29011.0 in the prior quarter.
- Across five years, Interest Expense - Others topped out at $507332.0 in Q2 2021 and bottomed at $24168.0 in Q2 2020.
- Historically, Interest Expense - Others has averaged $247464.3 across 5 years, with a median of $243840.5 in 2018.
- The sharpest annual moves came in 2020 and 2021: Interest Expense - Others sank 92.63% in 2020, then surged 1999.19% in 2021.
- Over 5 years, Interest Expense - Others stood at $283247.0 in 2018, then surged by 51.18% to $428225.0 in 2019, then sank by 46.83% to $227683.0 in 2020, then declined by 6.09% to $213815.0 in 2021, then sank by 78.2% to $46613.0 in 2022.
- According to Business Quant data, Interest Expense - Others over the past three periods registered $46613.0, $29011.0, and $213815.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioRestorative Therapies | 62,133.68 | -2.89 Mn | 17,964.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 46,613.00 |
| Mar 31, 2022 | 29,011.00 |
| Dec 31, 2021 | 213,815.00 |
| Sep 30, 2021 | 495,545.00 |
| Jun 30, 2021 | 507,332.00 |
| Mar 31, 2021 | 181,514.00 |
| Dec 31, 2020 | 227,683.00 |
| Sep 30, 2020 | 42,611.00 |
| Jun 30, 2020 | 24,168.00 |
| Mar 31, 2020 | 285,926.00 |
| Dec 31, 2019 | 428,225.00 |
| Sep 30, 2019 | 394,816.00 |
| Jun 30, 2019 | 327,967.00 |
| Mar 31, 2019 | 316,944.00 |
| Dec 31, 2018 | 283,247.00 |
| Sep 30, 2018 | 257,298.00 |
| Jun 30, 2018 | 230,383.00 |
| Mar 31, 2018 | 161,259.00 |
| Dec 31, 2017 | 160,701.00 |
| Sep 30, 2017 | 114,202.00 |